Travere Therapeutics Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Travere Therapeutics Inc (TVTX) SEC filings

Travere Therapeutics Inc (TVTX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported TVTX revenue for 2025-12-31 was $490.7M. Net income was -$25.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. TVTX currently screens at market cap $1.33B. The TVTX filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Travere Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for TVTX — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

TVTX SEC filings FAQ

What is the latest TVTX SEC filing?

The latest cached Travere Therapeutics Inc (TVTX) filing on this page is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/tvtx

What is the latest TVTX filing accession number?

The latest cached Travere Therapeutics Inc (TVTX) accession number on this page is 0001438533-26-000068. Filing: https://lician.com/sec/tvtx/0001438533-26-000068

Which item codes are on the latest TVTX filing?

Cached item codes on the latest Travere Therapeutics Inc (TVTX) 8-K are 5.02, 9.01.

How many TVTX SEC filings are listed on this page?

This page lists 4 cached Travere Therapeutics Inc (TVTX) SEC filings. Filings: https://lician.com/sec/tvtx

What events are listed on the TVTX SEC page?

Cached event headlines on this Travere Therapeutics Inc (TVTX) SEC page: "TVTX earnings". Events: https://lician.com/sec/tvtx

What are TVTX's latest revenue and net income?

Latest cached Travere Therapeutics Inc (TVTX) revenue for Dec 31, 2025 was $490.7M. Net income was -$25.5M. Statements: https://lician.com/financials/tvtx